Lecanemab
-
‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s diseaseThe treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and China.CanadaOct 29
-
Experimental Alzheimer’s drug slows disease, researchers say. Will it make a difference?An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening, researchers reported Tuesday.HealthNov 30, 2022
